Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.

导出 LinkOut

翻译打印收藏纠错

第一作者： Miikka,Tarkia

第一单位： Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland Department of Pharmacology, University of Helsinki, Helsinki, Finland.

作者： Miikka,Tarkia ^[1] ; Christoffer,Stark ^[2] ; Matti,Haavisto ^[3] ; Rasmus,Kentala ^[2] ; Tommi,Vähäsilta ^[4] ; Timo,Savunen ^[4] ; Marjatta,Strandberg ^[5] ; Virva,Saunavaara ^[3] ; Tuula,Tolvanen ^[3] ; Mika,Teräs ^[3] ; Mikko,Pietilä ^[5] ; Leena,Nyman ^[6] ; Emma,Duvall ^[7] ; Pekka,Saukko ^[8] ; Jouko,Levijoki ^[6] ; Anne,Roivainen ^[9] ; Antti,Saraste ^[10] ; Juhani,Knuuti ^[3]

作者单位： Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland Department of Pharmacology, University of Helsinki, Helsinki, Finland. ^[1] Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland. ^[2] Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland. ^[3] Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland Heart Center, Turku University Hospital and University of Turku, Turku, Finland. ^[4] Heart Center, Turku University Hospital and University of Turku, Turku, Finland. ^[5] Orion Corporation Orion Pharma, Espoo, Finland. ^[6] Quotient Bio Analytical Sciences, Fordham, UK. ^[7] Department of Forensic Medicine, University of Turku, Turku, Finland. ^[8] Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland Turku Center for Disease Modeling, University of Turku, Turku, Finland. ^[9] Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland Heart Center, Turku University Hospital and University of Turku, Turku, Finland Institute of Clinical Medicine, University of Turku, Turku, Finland. ^[10]